RESEARCH PAPER
Effect of IEM 1460 – a selective antagonist of GluR2-lacking AMPA receptors – on the action of conventional antiepileptic drugs against maximal electroshock in mice
Kinga Borowicz 1  
,  
 
 
More details
Hide details
1
Experimental Neuropathophysiology Unit, Department of Pathophysiology, Medical University, Lublin, Poland
CORRESPONDING AUTHOR
Kinga Borowicz   

Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland.
 
J Pre Clin Clin Res. 2007;1(1):39–40
KEYWORDS
ABSTRACT
The objective of the study was to determine the effect of combined treatment with IEM-1460 (a selective GluR2- lacking, Ca2+ permeable AMPA receptors) and conventional antiepileptic drugs: CBZ (carbamazepine), valproate (VPA), phenobarbital (PB), and phenytoin (PHT) against maximal electroshock-induced convulsions in mice. IEM- 1460 (up to 30 mg/kg) did not show anticonvulsant action in the test for electroconvulsive threshold. The substance did not influence the antiseizure effectiveness of antiepileptic drugs. This may indicate that not all AMPA receptor antagonists may be useful as additive drugs in the complex therapy of epilepsy. On the other hand, the GluR2-lacking, Ca2+ permeable subtype of AMPA receptors may be not crucial for seizure phenomena
 
REFERENCES (7)
1.
Tikhonov DB, Samoilova MV, Buldakova SL, Gmiro VE, Magazanik LG: Voltage-dependent block of native AMPA receptor channels by dicationic compounds. Br J Pharmacol 2000, 129, 265-274.
 
2.
Buldakova SL, Vorobjev VS, Sharonova IN, Samoilova MV, Magazanik LG: Characterization of AMPA receptor populations in rat brain cells by the use of subunit-specific open channel blocking drug, IEM-1460. Brain Res 1999, 846, 52-58.
 
3.
Schlesinger F, Tammena D, Krampfl K, Butler J: Two mechanisms of action of the adamantine derivative IEM-1460 on human AMPA-type glutamate receptors. Br J Pharmacol 2005, 145, 656-663.
 
4.
Borowicz KK, Kleinrok Z, Czuczwar SJ: The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam. Naunyn Schmiedebergs Arch Pharmacol 2000, 361, 629-635.
 
5.
Borowicz KK, Świąder M, Wielosz M, Czuczwar SJ: Influence of the combined treatment of LY 300164 (an AMPA/kainate receptor antagonist) with adenosine receptor agonists on the electroconvulsive threshold in mice. Eur Neuropsychopharmacol 2004, 14, 407-412.
 
6.
Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949, 96, 99-113.
 
7.
Borowicz KK, Gąsior M, Kleinrok Z, Czuczwar SJ: The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol 1995, 281, 319-326.
 
eISSN:1898-7516
ISSN:1898-2395